Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Bernstein

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|January 1, 1992
Is there a better way to deliver total body irradiation?F R Appelbaum, C C Badger, I D Bernstein, et al.
Blood|April 15, 1991
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaR J Berenson, W I Bensinger, R S Hill, et al.
Cancer Research|May 1, 1996
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cellsO W Press, D Shan, J Howell-Clark, et al.
Cancer|September 15, 1990
The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemiaW G Woods, F B Ruymann, B C Lampkin, et al.
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Blood|August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.
Blood|May 30, 1998
The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cellsB Varnum-Finney, L E Purton, M Yu, et al.
The Journal of Bone and Joint Surgery. British Volume|January 1, 1982
Improved three-year disease-free survival in osteogenic sarcomaW A Bleyer, J E Haas, P Feigl, et al.
Blood|May 15, 1997
MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemiaJ M Hilden, F O Smith, J L Frestedt, et al.
Blood|August 9, 2001
Loss of heterozygosity in childhood de novo acute myelogenous leukemiaD A Sweetser, C S Chen, A A Blomberg, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|January 1, 1992
Is there a better way to deliver total body irradiation?F R Appelbaum, C C Badger, I D Bernstein, et al.
Blood|April 15, 1991
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastomaR J Berenson, W I Bensinger, R S Hill, et al.
Cancer Research|May 1, 1996
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cellsO W Press, D Shan, J Howell-Clark, et al.
Cancer|September 15, 1990
The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemiaW G Woods, F B Ruymann, B C Lampkin, et al.
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Blood|August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.
Blood|May 30, 1998
The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cellsB Varnum-Finney, L E Purton, M Yu, et al.
The Journal of Bone and Joint Surgery. British Volume|January 1, 1982
Improved three-year disease-free survival in osteogenic sarcomaW A Bleyer, J E Haas, P Feigl, et al.
Blood|May 15, 1997
MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemiaJ M Hilden, F O Smith, J L Frestedt, et al.
Blood|August 9, 2001
Loss of heterozygosity in childhood de novo acute myelogenous leukemiaD A Sweetser, C S Chen, A A Blomberg, et al.
Pageof 13